Investor homePress releasesFinancial reportsShare informationCEO's messageShareholder meetingsGovernance
No items found.

Press releases

2021
2021-11-18 20:08
REG
MAR

Updated indicative timetable for Cell Impact's fully guaranteed rights issue

Cell Impact AB (Nasdaq First North Growth Market: CI B) ("Cell Impact" or the "Company") today announces an updated indicative timetable for the fully guaranteed Rights Issue. The updated indicative timetable deviates from the previously communicated indicative timetable due to a postponed prospectus approval as a result of high workload for the Swedish Financial Supervisory Authority's prospectus unit.

Read more
2021
2021-11-16 16:48
REG
MAR

Extraordinary general meeting of Cell Impact

An extraordinary general meeting of Cell Impact AB (publ) was held on 16 November 2021 whereby the shareholders, inter alia, authorized the board of directors to resolve upon issue of shares, warrants and/or convertibles.

Read more
2021
2021-10-28 21:10
REG
MAR

Notice of extraordinary general meeting of Cell Impact

The shareholders of Cell Impact AB (publ), reg. no. 556576-6655, are hereby invited to participate in an extraordinary general meeting on Tuesday 16 November 2021.

Read more
2021
2021-10-28 21:09
REG
MAR

The Board of Directors in Cell Impact intends to resolve on a fully guaranteed rights issue of up to approximately SEK 350 million

The Board of Directors in Cell Impact AB (Nasdaq First North Growth Market: CI B) ("Cell Impact" or the "Company") today announces its intention to resolve on a fully guaranteed rights issue of series B shares of up to approximately SEK 350 million (the "Rights Issue"). An Extra General Meeting is proposed to authorize the Board of Directors to resolve on the Rights Issue. The Extra General Meeting intends to be held on November 16, 2021 and the notice will be announced through a separate press release. The purpose of the Rights Issue is to ensure continued financing of Cell Impact's business plan, which includes increasing the Company's production capacity. Together with existing cash, the net proceeds from the Rights Issue is expected to be sufficient to finance the Company's business plan to mid-2023 provided that the Rights Issue generates gross proceeds of approximately SEK 350 million.

Read more
2021
2021-10-22 9:03
REG
MAR

Cell Impact reports third quarter results: Continued strong growth

Cell Impact AB (Nasdaq First North GM: CI B) reports the following financial summary for the third quarter.

Read more
2021
2021-10-07 15:40
REG
MAR

Cell Impact brings forward publication of third interim report

Read more
2021
2021-09-03 16:33
REG
MAR

Cell Impact strengthens management with new CHRO

Cell Impact AB (Nasdaq First North GM: Cell Impact AB (Nasdaq First North GM: CI B) is pleased to announce that Karina Sick Larsson has been appointed as Chief Human Resources Officer (CHRO) and will start her position on September 16, 2021. Karina will be responsible for the company's human resources function with a focus on organizational development.

Read more
2021
2021-08-25 10:32
REG
MAR

Cell Impact reports second quarter results for 2021: Strong growth

Cell Impact AB (Nasdaq First North GM: CI B) reports the following financial summary for the first quarter.

Read more
2021
2021-08-09 16:39
REG
MAR

Extraordinary general meeting of Cell Impact AB

An extraordinary general meeting of Cell Impact AB (Nasdaq First North GM: CI B) was held on August 9, 2021.

Read more
2021
2021-07-07 18:45
REG
MAR

Notice of extraordinary general meeting of Cell Impact

The shareholders of Cell Impact AB (Nasdaq First North GM: CI B), reg. no. 556576-6655, are hereby invited to participate in an extraordinary general meeting on Monday 9 August 2021.

Read more
2021
2021-07-05 17:06
REG
MAR

Cell Impact Japan Inc. receives order worth SEK 5.3 million

The order is for development of flow plate tooling and flow plate prototype production and will be delivered duringthe third quarter of 2021. This order is a continuation of earlier established activities in Japan as part of the cooperation with NKC Japan.

Read more
2021
2021-05-12 17:51
REG
MAR

Cell Impact strengthens management with new COO

Cell Impact AB (Nasdaq First North GM: CI B) is pleased to announce that Daniel Vallin has been appointed new Chief Operating Officer (COO) and will start his new position on August 16, 2021. He will succeed Tord Lätt, who will take over the role of Chief Project Manager (CPO) with responsibility for Cell Impact's automation development program.

Read more
2021
2021-05-07 10:06
REG
MAR

Cell Impact reports first quarter results for 2021

Cell Impact AB (Nasdaq First North GM: CI B) reports the following financial summary for the first quarter.

Read more
2021
2021-04-22 18:52
REG
MAR

Annual general meeting 2021 of Cell Impact

Cell Impact AB's (Nasdaq First North GM: CI B) annual general meeting for the financial year 2020 was held on 22 April, 2021.

Read more
2021
2021-03-31 15:54
REG
MAR

Cell Impact Japan Inc. office now opened

Located in the Minato-ku district in central Tokyo, Cell Impact Japan Inc.'s mission is to market and position Cell Impact in the growing Japanese hydrogen economy.

Read more
2021
2021-03-26 10:55
REG
MAR

Cell Impact publishes Annual Report for 2020

Read more
2021
2021-03-19 15:37
REG
MAR

Notice of the annual general meeting of Cell Impact

The shareholders of Cell Impact AB (publ), reg. no. 556576-6655, are hereby invited to participate in the annual general meeting to be held on Thursday, 22 April 2021.

Read more
2021
2021-03-15 18:07
REG
MAR

Nowogen Technology places MSEK 1.3 order for serial production of flow plates

Cell Impact AB (Nasdaq First North GM: CI B) has received an order worth MSEK 1.3 for serial production of bipolar flow plates from Beijing-based Nowogen Technology in China. The order is a continuation of the prototype order that Nowogen placed in September last year.

Read more
2021
2021-03-12 15:19
REG
MAR

Cell Impact receives SEK 42 million order from Plug Power for new production line and flow plates

Cell Impact AB (Nasdaq First North GM: CI B) has received an order worth SEK 42 million from world-leading fuel cell supplier Plug Power Inc for a Cell Impact Forming™ production line and flow plates for delivery during 2021.

Read more
2021
2021-02-19 9:12
REG
MAR

Cell Impact reports fourth quarter results for 2020

Cell Impact AB (Nasdaq First North GM: CI B) reports the following financial summary for the fourth quarter.

Read more
2021
2021-01-12 16:29
REG
MAR

Cell Impact appoints China Country Manager

Cell Impact (Nasdaq First North Growth Market: CI B) has appointed Mr. Forrest Zhang as Country Manager in China. Mr. Zhang will be based in Shanghai and will begin his new position on May 3, 2021.

Read more
2020
2020-12-03 8:54
REG
MAR

Cell Impact announces new strategy in Japan

In 2019, Cell Impact (Nasdaq First North Growth Market: CI B) and Nakanishi Metal Works Co. Ltd (NKC)announced a Memorandum of Understanding (MoU, see press release 2019-08-29) aimed at exploring an international business development collaboration. On December 3, following a year-long feasibility study, NKC and Cell Impact jointly concluded that there were not enough mutual synergies to justify further deepening the cooperation. NKC will remain a valued potential partner in future business ventures.

Read more
2020
2020-11-05 9:03
REG
MAR

Cell Impact reports third quarter results for 2020

Cell Impact AB (Nasdaq First North GM: CI B) reports the following financial summary for the third quarter.

Read more
2020
2020-10-13 12:07
REG
MAR

Cell Impact opens new Karlskoga factory for production of flow plates

Cell Impact AB (Nasdaq First North Growth Market: CI B) announces that the new production facility in Karlskoga, Brickegården, is now ready for production of flow plates. With a strong cash reserve, the company is now increasing the pace of positioning itself as a global volume supplier to the growing fuel cell industry.

Read more
2020
2020-10-07 1:40
REG
MAR

Cell Impact has carried out a directed share issue of SEK 175 million

The Board of Directors of Cell Impact AB (Nasdaq First North Growth Market: CI B) ("Cell Impact" or the "Company") has, based on the authorization granted by the annual general meeting on April 16, 2020, resolved on a directed issue of 7,000,000 series B shares at a subscription price of SEK 25 per share (the "Share Issue"), which means that the Company raises SEK 175,000,000 before transaction costs. The subscription price in the share issue has been determined through an accelerated bookbuilding procedure, performed by Carnegie Investment Bank AB (publ) and Stockholm Corporate Finance AB, and corresponds to a discount of approximately 6.7 percent compared to the closing price on Nasdaq First North Growth Market as of October 6, 2020. Several Swedish and international institutional investors, e.g. BNP Paribas Energy Transition Fund, DNB Asset Management (including the funds DNB Miljøinvest, DNB Renewable Energy and DNB Disruptive Opportunities) and Cicero Fonder, participated in the Share Issue.

Read more
2020
2020-10-06 19:50
REG
MAR

Cell Impact announces intention to carry out a directed issue of approximately 7 million series B shares

Cell Impact AB (Nasdaq First North Growth Market: CI B) ("Cell Impact" or the "Company") hereby announces its intention to, based on the authorization granted by the annual general meeting held on April 16, 2020, execute a share issue of approximately 7 million series B shares in the Company directed to Swedish and international institutional investors (the "Share Issue"). The Company has retained Carnegie Investment Bank AB (publ) as Sole Global Coordinator and Sole Bookrunner and Stockholm Corporate Finance AB as Co-manager in connection with the Share Issue (together the "Managers"). The subscription price and the total number of new shares in the Share Issue will be determined through an accelerated bookbuilding procedure (the "Bookbuilding") led by the Managers and will commence immediately following the announcement of this press release.

Read more
2020
2020-09-02 17:59
REG
MAR

Nowogen Technology places order for production of flow plates

Cell Impact AB (Nasdaq First North GM: CI B) has received an order worth 1.5 MSEK for prototype production of bipolar flow plates from Nowogen Technology. The order is a supplemental order to a previous tooling and development order that Cell Impact received in November 2018. Delivery is scheduled to begin in the fourth quarter of 2020 and be completed during the first quarter of 2021.

Read more
2019
2019-12-05 15:00
REG
MAR

Cell Impact is moving to a new larger production facility

During the second quarter of 2020, Cell Impact AB (publ) will begin a move to larger factory premises in Karlskoga. The new location, which is close to the current premises, makes it possible to build a significantly larger production capacity to increase delivery volumes in line with a growing order book and future demand.

Read more
2019
2019-11-18 14:00
REG
MAR

Cell Impact recruits COO

Cell Impact AB (publ) has recruited Tord Lätt to the company's management team in the role of COO (Chief Operating Officer). Tord is 53 years old and has a solid operational background with a primary focus on setting up and improving efficiency in industrial manufacturing. He will take up the position in December and will be responsible for developing and managing Cell Impact's operations.

Read more
2019
2019-09-02 12:30
REG
MAR

Cell Impact receives VINNOVA funding for collaboration with RISE on future production technology

Cell Impact AB (publ) has initiated a collaboration with RISE IVF AB on the next generation of production technology for the production of metal flow plates for hydrogen-fueled fuel cells. The project runs over six months and is jointly financed by Cell Impact and Vinnova.

Read more
2019
2019-08-29 16:16
REG
MAR

Cell Impact and Japanese NKC strengthen cooperation

Cell Impact AB (publ) and the Japanese industrial group Nakanishi Metal Works Co. Ltd. (NKC) deepens its cooperation by signing a Memorandum of Understanding (MoU) on international business development.

Read more
2019
2019-08-29 16:15
REG
MAR

Cell Impact carries through a directed share issue of approximately SEK 5 million

Cell Impact AB (publ) announces that the Board, with the support of the share issue authorization from the Annual General Meeting on April 11, 2019, today has resolved upon a directed share issue of series B shares with a value of approximately SEK 5 million. The share issue is directed to the Japanese industrial group Nakanishi Metal Works Co. Ltd. (NKC), which has entered into a subscription undertaking of approximately SEK 4.5 million, and Mr. Shigeru Nakagawa, Executive Officer, NKC New Business Division, who has entered into a subscription undertaking of approximately SEK 0.5 million.

Read more
2019
2019-04-17 11:10
REG
MAR

Cell Impact partners with large Japanese automotive supplier

Cell Impact AB (publ) has received a 3.4 MSEK development and technology validation order from Nakanishi Metal Works Co. Ltd (NKC) in Osaka, Japan. The order encompasses both a technical enhancement to our forming technology and a limited flow plate validation production run for a global leading automotive manufacturer.

Read more
2018
2018-10-30 14:00
REG
MAR

Cell Impact's first recruitment in China

Cell Impact AB (publ) has recruited Ms. Tingting Guan as its first local resource in China, starting in October. Tingting Guan has a doctorate in fuel cell systems from the Royal Institute of Technology in Stockholm, and she will be based in Hangzhou City, Zhejiang Province. 

Read more
2018
2018-01-12 10:00
REG
MAR

Cell Impact strengthens management and boosts activity in Europe

The use of fuels cells is intensifying in Euorpe and Cell Impact AB (publ) has decided to expand its presence in this market. The company has therefore recruited Mr. Achim Zeiss to Cell Impact's management team as Area Manager Europe, effective January 8, 2018.

Read more
MAR
- Insider information
REG
- Regulatory
- Geographic restriction
Documents prior to September 2020 are not available in English. Please visit the Swedish pages for older documents.
Information provided by